Home Hospice Care Subsidy to Increase by 30 Percent

Why It Matters

Higher subsidies and performance incentives could expand home hospice capacity, easing hospital strain and improving patient dignity. The policy also signals Taiwan's commitment to a regulated, ethically grounded end‑of‑life framework.

Key Takeaways

• Home hospice subsidy raised up to 30% by Taiwan's MOHW.
• Hospital hospice cases remain 80% despite subsidy push.
• Performance rewards require 60% of extra pay to frontline staff.
• More than 100 hospitals have applied for the incentive program.
• Euthanasia stays illegal; policy emphasizes advance directives and palliative care.

Pulse Analysis

Taiwan has long been a leader in palliative care, with its National Health Insurance covering hospice services since 1996. Yet roughly 80 percent of hospice encounters still occur in hospitals, prompting the Ministry of Health and Welfare to boost home hospice subsidies by up to 30 percent. The increase is tied to a pay‑for‑performance framework that grades hospital programs as good, excellent or outstanding, ensuring that the majority of additional funds reward the nurses and physicians delivering bedside care.

The incentive structure is designed to accelerate a shift toward community‑based end‑of‑life care. By mandating that 60 percent of the extra payment flow directly to frontline staff, the government hopes to attract and retain skilled hospice teams, while the tiered scoring system creates clear quality benchmarks. Over 100 hospitals have already entered the program, and on‑site evaluations slated between now and October will determine final scores and corresponding payouts. If successful, the model could reduce hospital occupancy, lower acute‑care costs, and improve patient satisfaction by allowing more families to experience a dignified death at home.

Beyond financial mechanics, the policy reflects Taiwan's nuanced stance on end‑of‑life ethics. While active euthanasia remains criminalized, the government emphasizes advance medical decisions under the Hospice Palliative Care Act and the Patient Right to Autonomy Act. This balanced approach mirrors trends in other high‑income economies that prioritize palliative options over lethal interventions. As the incentive program matures, it may serve as a template for other nations seeking to expand home hospice services without compromising ethical standards.